Viewing negative mentions of localization of IL2 (H. sapiens) in lymphocytes

Full-text article links are indicated by after the article reference.

Document Target Regulator Anatomy Sentence
Vaith et al. (1985)interleukin-2lymphocytesThere was no measurable interleukin-2 (IL-2) secretion of peripheral blood lymphocytes.
Voss et al. (1989)IL-2lymphocytesFollowing cessation of the IL-2 infusion these activated lymphocytes return to the peripheral circulation and do not secrete TAC as vigorously as while influenced directly by the IL-2 infusion.
Emara and Carroll (1992)recombinant IL-2PBLsHowever, crosslinking CD7 and/or FcRmu of PBLs significantly reduced phytohemagglutinin (PHA)-induced IL-2 production and rendered PBLs unable to utilize exogenously added human recombinant IL-2 (rIL-2).
Sivanandham and Mukherji (1989)IL-2PBLOne of these two lines, referred to as TFTx, established from the autologous tumor activated peripheral blood lymphocytes (PBL), grows in culture without any exogenous interleukin-2 (IL-2), secretes no detectable amount of IL-2 or gamma interferon (IFN) or tumor necrosis factor (TNF) alpha or beta.
Inaba and Steinman (1987)IL-2lymphocytesHowever, the bound anti-CD4-coated lymphocytes are unable to release IL-2.
Matsui et al. (1996)IL-2IHLNW-NA IHL did not secrete IL-2 during this process, indicating that NW-NA IHL were in a state of functional anergy soon after the i.v. administration of SEB.